These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7757071)

  • 21. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation.
    Cone RD; Lu D; Koppula S; Vage DI; Klungland H; Boston B; Chen W; Orth DN; Pouton C; Kesterson RA
    Recent Prog Horm Res; 1996; 51():287-317; discussion 318. PubMed ID: 8701084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic studies of the mouse mutations mahogany and mahoganoid.
    Miller KA; Gunn TM; Carrasquillo MM; Lamoreux ML; Galbraith DB; Barsh GS
    Genetics; 1997 Aug; 146(4):1407-15. PubMed ID: 9258683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis of the pleiotropic phenotype of mice carrying the hypervariable yellow (Ahvy) mutation at the agouti locus.
    Argeson AC; Nelson KK; Siracusa LD
    Genetics; 1996 Feb; 142(2):557-67. PubMed ID: 8852853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and transgenic studies of the mouse agouti gene provide insight into the mechanisms by which mammalian coat color patterns are generated.
    Millar SE; Miller MW; Stevens ME; Barsh GS
    Development; 1995 Oct; 121(10):3223-32. PubMed ID: 7588057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesity.
    Mynatt RL; Miltenberger RJ; Klebig ML; Zemel MB; Wilkinson JE; Wilkinson WO; Woychik RP
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):919-22. PubMed ID: 9023357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.
    Blanchard SG; Harris CO; Ittoop OR; Nichols JS; Parks DJ; Truesdale AT; Wilkison WO
    Biochemistry; 1995 Aug; 34(33):10406-11. PubMed ID: 7544613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the agouti gene in the yellow obese syndrome.
    Miltenberger RJ; Mynatt RL; Wilkinson JE; Woychik RP
    J Nutr; 1997 Sep; 127(9):1902S-1907S. PubMed ID: 9278579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A biochemical function for attractin in agouti-induced pigmentation and obesity.
    He L; Gunn TM; Bouley DM; Lu XY; Watson SJ; Schlossman SF; Duke-Cohan JS; Barsh GS
    Nat Genet; 2001 Jan; 27(1):40-7. PubMed ID: 11137996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neomorphic agouti mutations in obese yellow mice.
    Duhl DM; Vrieling H; Miller KA; Wolff GL; Barsh GS
    Nat Genet; 1994 Sep; 8(1):59-65. PubMed ID: 7987393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agouti signal protein regulation in human melanoma cells.
    Voisey J; Kelly G; Van Daal A
    Pigment Cell Res; 2003 Feb; 16(1):65-71. PubMed ID: 12519127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular basis for dominant yellow agouti coat color mutations.
    Perry WL; Copeland NG; Jenkins NA
    Bioessays; 1994 Oct; 16(10):705-7. PubMed ID: 7980472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor.
    Lu D; Willard D; Patel IR; Kadwell S; Overton L; Kost T; Luther M; Chen W; Woychik RP; Wilkison WO
    Nature; 1994 Oct; 371(6500):799-802. PubMed ID: 7935841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of leptin by agouti.
    Claycombe KJ; Xue BZ; Mynatt RL; Zemel MB; Moustaid-Moussa N
    Physiol Genomics; 2000 Apr; 2(3):101-5. PubMed ID: 11015588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agouti structure and function: characterization of a potent alpha-melanocyte stimulating hormone receptor antagonist.
    Willard DH; Bodnar W; Harris C; Kiefer L; Nichols JS; Blanchard S; Hoffman C; Moyer M; Burkhart W; Weiel J
    Biochemistry; 1995 Sep; 34(38):12341-6. PubMed ID: 7547977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular pharmacology of Agouti protein in vitro and in vivo.
    Barsh GS; Ollmann MM; Wilson BD; Miller KA; Gunn TM
    Ann N Y Acad Sci; 1999 Oct; 885():143-52. PubMed ID: 10816647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome.
    Kesterson RA; Huszar D; Lynch CA; Simerly RB; Cone RD
    Mol Endocrinol; 1997 May; 11(5):630-7. PubMed ID: 9139806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An agouti mutation lacking the basic domain induces yellow pigmentation but not obesity in transgenic mice.
    Miltenberger RJ; Mynatt RL; Bruce BD; Wilkison WO; Woychik RP; Michaud EJ
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8579-84. PubMed ID: 10411918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mouse mahogany locus encodes a transmembrane form of human attractin.
    Gunn TM; Miller KA; He L; Hyman RW; Davis RW; Azarani A; Schlossman SF; Duke-Cohan JS; Barsh GS
    Nature; 1999 Mar; 398(6723):152-6. PubMed ID: 10086356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agouti regulates adipocyte transcription factors.
    Mynatt RL; Stephens JM
    Am J Physiol Cell Physiol; 2001 Apr; 280(4):C954-61. PubMed ID: 11245612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of the mouse agouti locus.
    Bultman SJ; Michaud EJ; Woychik RP
    Cell; 1992 Dec; 71(7):1195-204. PubMed ID: 1473152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.